Madison Asset Management LLC purchased a new position in AMN Healthcare Services, Inc. (NYSE:AMN - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 14,006 shares of the company's stock, valued at approximately $1,049,000.
Other institutional investors have also added to or reduced their stakes in the company. Assenagon Asset Management S.A. acquired a new stake in AMN Healthcare Services in the fourth quarter worth about $5,361,000. American Century Companies Inc. lifted its holdings in shares of AMN Healthcare Services by 13.1% during the third quarter. American Century Companies Inc. now owns 177,151 shares of the company's stock worth $15,090,000 after purchasing an additional 20,510 shares during the period. Pacer Advisors Inc. lifted its holdings in shares of AMN Healthcare Services by 145.8% during the fourth quarter. Pacer Advisors Inc. now owns 1,396,603 shares of the company's stock worth $104,578,000 after purchasing an additional 828,390 shares during the period. Boston Partners lifted its holdings in shares of AMN Healthcare Services by 102.7% during the fourth quarter. Boston Partners now owns 2,884,550 shares of the company's stock worth $216,038,000 after purchasing an additional 1,461,541 shares during the period. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in shares of AMN Healthcare Services during the fourth quarter worth about $1,006,000. Institutional investors and hedge funds own 99.23% of the company's stock.
AMN Healthcare Services Trading Up 3.0 %
Shares of AMN Healthcare Services stock traded up $1.63 during trading hours on Friday, hitting $55.94. The company's stock had a trading volume of 722,864 shares, compared to its average volume of 799,754. AMN Healthcare Services, Inc. has a twelve month low of $53.00 and a twelve month high of $112.44. The firm has a fifty day moving average of $58.42 and a 200-day moving average of $65.37. The stock has a market cap of $2.13 billion, a price-to-earnings ratio of 15.04 and a beta of 0.22. The company has a debt-to-equity ratio of 1.49, a quick ratio of 1.27 and a current ratio of 1.27.
AMN Healthcare Services (NYSE:AMN - Get Free Report) last posted its earnings results on Thursday, May 9th. The company reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.93 by $0.04. AMN Healthcare Services had a return on equity of 31.39% and a net margin of 4.13%. The firm had revenue of $820.90 million for the quarter, compared to analyst estimates of $816.54 million. During the same quarter in the prior year, the company earned $2.49 EPS. AMN Healthcare Services's revenue was down 27.1% on a year-over-year basis. Research analysts forecast that AMN Healthcare Services, Inc. will post 3.32 EPS for the current year.
Insider Buying and Selling
In other news, Director Jorge A. Caballero bought 2,000 shares of the firm's stock in a transaction that occurred on Wednesday, March 6th. The shares were purchased at an average price of $56.80 per share, with a total value of $113,600.00. Following the purchase, the director now owns 2,437 shares in the company, valued at $138,421.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.93% of the stock is owned by corporate insiders.
Analyst Upgrades and Downgrades
AMN has been the subject of a number of research reports. JMP Securities reaffirmed a "market outperform" rating and set a $75.00 target price on shares of AMN Healthcare Services in a report on Friday, May 10th. Bank of America boosted their price target on AMN Healthcare Services from $61.00 to $65.00 and gave the company a "neutral" rating in a report on Wednesday, May 15th. Truist Financial cut their price objective on AMN Healthcare Services from $88.00 to $70.00 and set a "buy" rating for the company in a research report on Monday, April 22nd. BMO Capital Markets cut their price objective on AMN Healthcare Services from $80.00 to $71.00 and set an "outperform" rating for the company in a research report on Monday, May 13th. Finally, Benchmark restated a "hold" rating on shares of AMN Healthcare Services in a research report on Tuesday, May 28th. Five equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat, AMN Healthcare Services has a consensus rating of "Hold" and a consensus price target of $75.57.
Check Out Our Latest Analysis on AMN
AMN Healthcare Services Profile
(Free Report)
AMN Healthcare Services, Inc provides healthcare workforce solutions and staffing services to healthcare facilities in the United States. It operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. The Nurse and Allied Solutions segment offers travel nurse staffing, labor disruption staffing, local staffing, international nurse and allied permanent placement, and allied staffing solutions.
Read More
- Five stocks we like better than AMN Healthcare Services
- What is Forex and How Does it Work?
- MarketBeat Week in Review – 5/27 - 5/31
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Foot Locker’s Quarter Sends Doubters Running
- What to Know About Investing in Penny Stocks
- Costco Wholesale Can Hit New Highs; A Rebound Is Coming
→ Elon to Transform U.S. Economy? (From Porter & Company) (Ad)
Should you invest $1,000 in AMN Healthcare Services right now?
Before you consider AMN Healthcare Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMN Healthcare Services wasn't on the list.
While AMN Healthcare Services currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
20 Stocks to Sell Now
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
